Topic: PHARMAMAR
5 results were found.
PharmaMar confirms in vitro activity of plitidepsin against several variants, including Delta and Omicron - January 12, 2022
PharmaMar signs licensing and commercialization agreement with Lotus Pharmaceutical for lurbinectedin in Taiwan - November 11, 2021
Spain: PharmaMar to begin Phase 3 trial of drug to treat COVID-19 - April 30, 2021
PharmaMar's drug reduces COVID-19 viral loads 99% - January 26, 2021
PharmaMar names Pascal Besman as COO of PharmaMar U.S. - November 17, 2016